Enzo Emanuele

Last updated
Enzo Emanuele
Enzo emanuele.jpg
Born (1977-06-10) June 10, 1977 (age 46)
Alma materPavia Medical School
- University of Pavia
Known for Biomarker discovery, Interdisciplinary research
AwardsZdenek Klein Award for Human Ethology (2008), Giovanni Galli Prize for the Study of Atherosclerosis (2009)
Scientific career
Fields Clinical Pathology

Enzo Emanuele (born June 10, 1977) is an Italian clinical pathologist known for his interdisciplinary research in the field of biological psychology. He has studied the biochemical basis of romantic interpersonal attraction and identified the neurotrophin nerve growth factor (NGF) as a key biochemical mediator of falling in love. [1] The implications of this research have been criticized in the popular press. [2] In 2008, his genetic research, which showed an association between serotonin and dopamine receptor gene polymorphisms and certain love traits, [3] was awarded with the International Zdenek Klein Award for Human Ethology from Charles University in Prague, Czech Republic. [4]

Contents

Emanuele is also known for his studies on biomarkers of atherosclerosis. [4] On October 3, 2009, Enzo Emanuele was awarded by the Italian Society for the Study of Atherosclerosis (SISA), Lombardy Section, with the Giovanni Galli Prize for his scientific contributions in the field of cardiovascular biomarkers. [5]

He graduated as MD from the University of Pavia in Pavia, Italy [4] in 2002. [6]

Emanuele is Associate Editor of the journal Atherosclerosis. [4] He is also member of the editorial board of the Journal of Special Education and Rehabilitation. [7]

Contributions to science

Related Research Articles

<span class="mw-page-title-main">Donepezil</span> Medication used for dementia

Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. It appears to result in a small benefit in mental function and ability to function. Use, however, has not been shown to change the progression of the disease. Treatment should be stopped if no benefit is seen. It is taken by mouth or via a transdermal patch.

Glycation is the covalent attachment of a sugar to a protein, lipid or nucleic acid molecule. Typical sugars that participate in glycation are glucose, fructose, and their derivatives. Glycation is the non-enzymatic process responsible for many complications in diabetes mellitus and is implicated in some diseases and in aging. Glycation end products are believed to play a causative role in the vascular complications of diabetes mellitus.

Advanced glycation end products (AGEs) are proteins or lipids that become glycated as a result of exposure to sugars. They are a bio-marker implicated in aging and the development, or worsening, of many degenerative diseases, such as diabetes, atherosclerosis, chronic kidney disease, and Alzheimer's disease.

<span class="mw-page-title-main">Apolipoprotein</span> Proteins that bind lipids to transport them in body fluids

Apolipoproteins are proteins that bind lipids to form lipoproteins. They transport lipids in blood, cerebrospinal fluid and lymph.

<i>Griffonia simplicifolia</i> Species of legume

Griffonia simplicifolia is a woody climbing shrub native to West Africa and Central Africa. It grows to about 3 m, and bears greenish flowers followed by black pods.

<span class="mw-page-title-main">S100 protein</span> Family of vertebrate proteins involved in cell division and inflammation

The S100 proteins are a family of low molecular-weight proteins found in vertebrates characterized by two calcium-binding sites that have helix-loop-helix ("EF-hand-type") conformation. At least 21 different S100 proteins are known. They are encoded by a family of genes whose symbols use the S100 prefix, for example, S100A1, S100A2, S100A3. They are also considered as damage-associated molecular pattern molecules (DAMPs), and knockdown of aryl hydrocarbon receptor downregulates the expression of S100 proteins in THP-1 cells.

<span class="mw-page-title-main">Human serum albumin</span> Albumin found in human blood

Human serum albumin is the serum albumin found in human blood. It is the most abundant protein in human blood plasma; it constitutes about half of serum protein. It is produced in the liver. It is soluble in water, and it is monomeric.

<span class="mw-page-title-main">Apolipoprotein E</span> Cholesterol-transporting protein most notably implicated in Alzheimers disease

Apolipoprotein E (Apo-E) is a protein involved in the metabolism of fats in the body of mammals. A subtype is implicated in Alzheimer's disease and cardiovascular diseases. It is encoded in humans by the gene APOE.

<span class="mw-page-title-main">RAGE (receptor)</span> Protein-coding gene in the species Homo sapiens

RAGE, also called AGER, is a 35 kilodalton transmembrane receptor of the immunoglobulin super family which was first characterized in 1992 by Neeper et al. Its name comes from its ability to bind advanced glycation endproducts (AGE), which include chiefly glycoproteins, the glycans of which have been modified non-enzymatically through the Maillard reaction. In view of its inflammatory function in innate immunity and its ability to detect a class of ligands through a common structural motif, RAGE is often referred to as a pattern recognition receptor. RAGE also has at least one other agonistic ligand: high mobility group protein B1 (HMGB1). HMGB1 is an intracellular DNA-binding protein important in chromatin remodeling which can be released by necrotic cells passively, and by active secretion from macrophages, natural killer cells, and dendritic cells.

<span class="mw-page-title-main">Hyperhomocysteinemia</span> Medical condition

Hyperhomocysteinemia is a medical condition characterized by an abnormally high level of total homocysteine in the blood, conventionally described as above 15 μmol/L.

<span class="mw-page-title-main">LRP1</span> Mammalian protein found in Homo sapiens

Low density lipoprotein receptor-related protein 1 (LRP1), also known as alpha-2-macroglobulin receptor (A2MR), apolipoprotein E receptor (APOER) or cluster of differentiation 91 (CD91), is a protein forming a receptor found in the plasma membrane of cells involved in receptor-mediated endocytosis. In humans, the LRP1 protein is encoded by the LRP1 gene. LRP1 is also a key signalling protein and, thus, involved in various biological processes, such as lipoprotein metabolism and cell motility, and diseases, such as neurodegenerative diseases, atherosclerosis, and cancer.

<span class="mw-page-title-main">CD163</span> Protein-coding gene in the species Homo sapiens

CD163 is a protein that in humans is encoded by the CD163 gene. CD163 is the high affinity scavenger receptor for the hemoglobin-haptoglobin complex and in the absence of haptoglobin - with lower affinity - for hemoglobin alone. It also is a marker of cells from the monocyte/macrophage lineage. CD163 functions as innate immune sensor for gram-positive and gram-negative bacteria. The receptor was discovered in 1987.

<span class="mw-page-title-main">Sortilin 1</span> Protein-coding gene in the species Homo sapiens

Sortilin (SORT1) is a protein that in humans is encoded by the SORT1 gene on chromosome 1. This protein is a type I membrane glycoprotein in the vacuolar protein sorting 10 protein (Vps10p) family of sorting receptors. While it is ubiquitously expressed in many tissues, sortilin is most abundant in the central nervous system. At the cellular level, sortilin functions in protein transport between the Golgi apparatus, endosome, lysosome, and plasma membrane, leading to its involvement in multiple biological processes such as glucose and lipid metabolism as well as neural development and cell death. Moreover, the function and role of sortilin is now emerging in several major human diseases such as hypertension, atherosclerosis, coronary artery disease, Alzheimer’s disease, and cancer. The SORT1 gene also contains one of 27 loci associated with increased risk of coronary artery disease.

<span class="mw-page-title-main">Hydroxycarboxylic acid receptor 2</span> Protein-coding gene in the species Homo sapiens

Hydroxycarboxylic acid receptor 2 (HCA2), also known as GPR109A and niacin receptor 1 (NIACR1), is a protein which in humans is encoded (its formation is directed) by the HCAR2 gene and in rodents by the Hcar2 gene. The human HCAR2 gene is located on the long (i.e., "q") arm of chromosome 12 at position 24.31 (notated as 12q24.31). Like the two other hydroxycarboxylic acid receptors, HCA1 and HCA3, HCA2 is a G protein-coupled receptor (GPCR) located on the surface membrane of cells. HCA2 binds and thereby is activated by D-β-hydroxybutyric acid (hereafter termed β-hydroxybutyric acid), butyric acid, and niacin (also known as nicotinic acid). β-Hydroxybutyric and butyric acids are regarded as the endogenous agents that activate HCA2. Under normal conditions, niacin's blood levels are too low to do so: it is given as a drug in high doses in order to reach levels that activate HCA2.

<span class="mw-page-title-main">Alpha-7 nicotinic receptor</span>

The alpha-7 nicotinic receptor, also known as the α7 receptor, is a type of nicotinic acetylcholine receptor implicated in long-term memory, consisting entirely of α7 subunits. As with other nicotinic acetylcholine receptors, functional α7 receptors are pentameric [i.e., (α7)5 stoichiometry].

<span class="mw-page-title-main">ABCA7</span> Protein-coding gene in the species Homo sapiens

ATP-binding cassette sub-family A member 7 is a protein that in humans is encoded by the ABCA7 gene.

<span class="mw-page-title-main">Cholinesterase inhibitor</span> Chemicals which prevent breakdown of acetylcholine and butyrylcholine

Cholinesterase inhibitors (ChEIs), also known as anti-cholinesterase, are chemicals that prevent the breakdown of the neurotransmitter acetylcholine or butyrylcholine. This increases the amount of the acetylcholine or butyrylcholine in the synaptic cleft that can bind to muscarinic receptors, nicotinic receptors and others. This group of inhibitors is divided into two subgroups, acetylcholinesterase inhibitors (AChEIs) and butyrylcholinesterase inhibitors (BChEIs).

<span class="mw-page-title-main">3-Deoxyglucosone</span> Chemical compound

3-Deoxyglucosone (3DG) is a sugar that is notable because it is a marker for diabetes. 3DG reacts with protein to form advanced glycation end-products (AGEs), which contribute to diseases such as the vascular complications of diabetes, atherosclerosis, hypertension, Alzheimer's disease, inflammation, and aging.

<span class="mw-page-title-main">Rivastigmine</span> Chemical compound

Rivastigmine is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.

Azeliragon is a small-molecule RAGE inhibitor. It is developed by vTv Therapeutics for various cancers, including triple-negative breast cancer, pancreatic cancer.

References

  1. Emanuele E, Politi P, Bianchi M, Minoretti P, Bertona M, Geroldi D (Apr 2006). "Raised plasma nerve growth factor levels associated with early-stage romantic love". Psychoneuroendocrinology. 31 (3): 288–94. doi:10.1016/j.psyneuen.2005.09.002. ISSN   0306-4530. PMID   16289361. S2CID   18497668.
  2. Harris, John (29 November 2005). "Is love just a chemical?". The Guardian . Retrieved 28 August 2009.
  3. 1 2 Emanuele, E; Brondino, N; Pesenti, S; Re, S; Geroldi, D (Dec 2007). "Genetic loading on human loving styles". Neuro Endocrinology Letters. 28 (6): 815–21. ISSN   0172-780X. PMID   18063936.
  4. 1 2 3 4 "Associate Editors". European Atherosclerosis Society. Retrieved 24 March 2010.[ permanent dead link ]
  5. "Giovanni Galli Prize" (in Italian). Italian Society for the Study of Atherosclerosis (SISA), Lombardy Section. Archived from the original on 22 July 2011. Retrieved 6 October 2009.
  6. Page at Italian Federation of Medical Associations (FNOMCeO) [ permanent dead link ](in Italian)
  7. "Editorial Board of the Journal of Special Education and Rehabilitation". Archived from the original on 2009-09-16. Retrieved 2009-10-12.
  8. Falcone, C; Emanuele, E; D'angelo, A; Buzzi, Mp; Belvito, C; Cuccia, M; Geroldi, D (May 2005). "Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men". Arteriosclerosis, Thrombosis, and Vascular Biology. 25 (5): 1032–7. CiteSeerX   10.1.1.572.867 . doi:10.1161/01.ATV.0000160342.20342.00. ISSN   1079-5642. PMID   15731496. S2CID   18192387. Archived from the original (Free full text) on 2012-07-01. Retrieved 2009-08-25.
  9. Emanuele, E; D'angelo, A; Tomaino, C; Binetti, G; Ghidoni, R; Politi, P; Bernardi, L; Maletta, R; Bruni, Ac; Geroldi, D (Nov 2005). "Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia". Archives of Neurology. 62 (11): 1734–6. doi:10.1001/archneur.62.11.1734. ISSN   0003-9942. PMID   16286548.
  10. Geroldi, D; Falcone, C; Minoretti, P; Emanuele, E; Arra, M; D'angelo, A (Jul 2006). "High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans". Journal of the American Geriatrics Society. 54 (7): 1149–50. doi:10.1111/j.1532-5415.2006.00776.x. ISSN   0002-8614. PMID   16866696. S2CID   6142613.
  11. Emanuele, E; Politi, P; Bianchi, M; Minoretti, P; Bertona, M; Geroldi, D (Apr 2006). "Raised plasma nerve growth factor levels associated with early-stage romantic love". Psychoneuroendocrinology. 31 (3): 288–94. doi:10.1016/j.psyneuen.2005.09.002. ISSN   0306-4530. PMID   16289361. S2CID   18497668.
  12. Boso, M; Emanuele, E; Minoretti, P; Arra, M; Politi, P; Ucelli, Di; Barale, F (Dec 2006). "Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism". Neuroscience Letters. 410 (3): 169–73. doi:10.1016/j.neulet.2006.08.092. ISSN   0304-3940. PMID   17101220. S2CID   20272562.
  13. Boso, M; Emanuele, E; Politi, P; Pace, A; Arra, M; Ucelli, Di; Barale, F (Jan 2007). "Reduced plasma apelin levels in patients with autistic spectrum disorder". Archives of Medical Research. 38 (1): 70–4. doi:10.1016/j.arcmed.2006.08.003. ISSN   0188-4409. PMID   17174726.
  14. Emanuele, E; Lista, S; Ghidoni, R; Binetti, G; Cereda, C; Benussi, L; Maletta, R; Bruni, Ac; Politi, P (Aug 2009). "Chromosome 9p21.3 genotype is associated with vascular dementia and Alzheimer's disease". Neurobiology of Aging. 32 (7): 1231–5. doi:10.1016/j.neurobiolaging.2009.07.003. ISSN   0197-4580. PMID   19664850. S2CID   635821.
  15. Arra, M; Emanuele, E; Martinelli, V; Minoretti, P; Bertona, M; Geroldi, D (2007). "The M694V variant of the familial Mediterranean fever gene is associated with sporadic early-onset Alzheimer's disease in an Italian population sample". Dementia and Geriatric Cognitive Disorders. 23 (1): 55–9. doi:10.1159/000096743. ISSN   1420-8008. PMID   17090974. S2CID   44605756.
  16. Re, Simona; Zanoletti, Marco; Emanuele, Enzo (2009). "Association of inflammatory markers elevation with aggressive behavior in domestic dogs". Journal of Ethology. 27: 31–33. doi:10.1007/s10164-007-0079-3. S2CID   6585126.
  17. Re, S; Zanoletti, M; Emanuele, E (Mar 2008). "Aggressive dogs are characterized by low omega-3 polyunsaturated fatty acid status". Veterinary Research Communications. 32 (3): 225–30. doi:10.1007/s11259-007-9021-y. ISSN   0165-7380. PMID   17891468. S2CID   21948930.
  18. Emanuele, E; Brondino, N; Bertona, M; Re, S; Geroldi, D (May 2008). "Relationship between platelet serotonin content and rejections of unfair offers in the ultimatum game". Neuroscience Letters. 437 (2): 158–61. doi:10.1016/j.neulet.2008.04.006. ISSN   0304-3940. PMID   18448251. S2CID   11537582.
  19. Emanuele, E; Brondino, N; Re, S; Bertona, M; Geroldi, D (Jan 2009). "Serum omega-3 fatty acids are associated with ultimatum bargaining behavior". Physiology & Behavior. 96 (1): 180–3. doi:10.1016/j.physbeh.2008.09.020. ISSN   0031-9384. PMID   18940191. S2CID   17638261.
  20. Emanuele E, Bertona M, Geroldi D (2010). "A multilocus candidate approach identifies ACE and HIF1A as susceptibility genes for cellulite". Journal of the European Academy of Dermatology and Venereology. 24 (8): 930–5. doi:10.1111/j.1468-3083.2009.03556.x. PMID   20059631. S2CID   26214159. Archived from the original on 2012-12-10.